HIT vs SSTI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
HIT presents a high-risk profile characterized by a Piotroski F-Score of 4/9 (Stable) but severe technical deterioration. While the company exhibits strong revenue growth (53.10%) and an exceptionally clean balance sheet (Debt/Equity 0.01), it is trading at a massive premium to its Graham Number ($0.37) and Intrinsic Value ($0.14). The stock is currently in a freefall with a 0/100 technical trend and a 60.8% decline over the last six months, coupled with a poor earnings track record of 0/4 beats.
SSTI exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 2/9 and a consistent track record of missing earnings estimates (0/4 beats in the last year). While the company maintains a low debt-to-equity ratio and a reasonable Price-to-Sales ratio, its negative profit margins and liquidity issues (Current Ratio 0.85) are critical concerns. The long-term price performance is devastating, with an 80.2% decline over five years, and technical trends remain bearish despite a minor recent bounce. The disconnect between the analyst target price ($13.17) and the actual financial trajectory suggests a significant overestimation of recovery potential.
Compare Another Pair
Related Comparisons
HIT vs SSTI: Head-to-Head Comparison
This page compares Health In Tech, Inc. (HIT) and SoundThinking, Inc. (SSTI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.